Induction of sodium-dependent bile acid transporter messenger RNA, protein, and activity in rat ileum by cholic acid

doi:10.1053/gast.1997.v113.pm9352862

Gastroenterology

Volume 113, Issue 5, November 1997, Pages 1599-1608

https://doi.org/10.1053/gast.1997.v113.pm9352862 Get rights and content

Abstract

BACKGROUND & AIMS: The ileal sodium-dependent bile acid transporter reclaims bile acids from the intestinal lumen to preserve their enterohepatic recirculation. The present studies sought to determine the possible role of enteric bile acids in the molecular regulation of the apical bile acid transporter in rat ileal mucosa.

METHODS: Paired rats were fed a control diet or control diet plus cholic acid (1%) or ursodeoxycholic acid (1%) for 10 days. Other paired rats underwent biliary diversion for 72 hours, followed by intraduodenal infusion of taurocholate or fluid/electrolytes. Transporter protein, messenger RNA (mRNA), and activity were determined in the distal 15 cm of ileal mucosa.

RESULTS: Transporter protein and mRNA levels in cholic acid-fed rats increased approximately threefold above levels in paired rats fed the control diet (P < 0.02). Similarly, sodium-dependent [3H]taurocholate uptake into membrane vesicles from cholic acid-fed rats increased twofold above uptake into vesicles from control-fed rats because of a twofold increase in maximal transport velocity. In biliary- diverted rats (72-96 hours), transporter protein decreased to 57% +/- 5% of paired controls with intact enterohepatic circulation (P < 0.0001). The intraduodenal infusion of taurocholate (24 hours) in biliary-diverted rats resulted in a time-dependent reinduction of transporter protein expression (3.5-fold).

CONCLUSIONS: The expression of the ileal apical bile acid transporter is induced at a pretranslational level by free or taurine-conjugated cholic acid within the small intestine.

(Gastroenterology 1997 Nov;113(5):1599-608)

References (0)

Cited by (68)

Bile acid homeostasis in gastrointestinal and metabolic complications of cystic fibrosis
2019, Journal of Cystic Fibrosis
With the improved treatment of the pulmonary complications of cystic fibrosis (CF), gastrointestinal problems have become more important in the morbidity in CF. A hallmark of the gastrointestinal phenotype of CF, apart from pancreatic insufficiency, is a disruption of bile acid homeostasis. Bile acid homeostasis is important for many gastrointestinal processes including fat absorption, inflammation, microbial composition, as well as regulation of whole body energy metabolism. This review describes the impairment of bile acid homeostasis in CF, its possible consequences for gastrointestinal and metabolic complications and its potential as a target for therapy.
An important intestinal transporter that regulates the enterohepatic circulation of bile acids and cholesterol homeostasis: The apical sodium-dependent bile acid transporter (SLC10A2/ASBT)
2017, Clinics and Research in Hepatology and Gastroenterology
Citation Excerpt :
Similarly, in humans, the effects of BAs occur through FXR- and SHP-mediated repression of retinoic acid receptor/retinoid X receptor (RAR/RXR)-induced activation of the ASBT [20]. Different investigators have observed that the SLC10A2 gene is upregulated, downregulated, or neither by BAs [15–17,21–24]. The difference not only in the various investigated species, but in the lack of unification among experimental models that assess the effects of changes in the BA level on the expression and function of the ASBT might account for the discrepancies that have been observed [15,18,20,25,26].
The enterohepatic circulation of bile acids (BAs) is governed by specific transporters expressed in the liver and the intestine and plays a critical role in the digestion of fats and oils. During this process, the majority of the BAs secreted from the liver is reabsorbed in intestinal epithelial cells via the apical sodium-dependent bile acid transporter (ASBT/SLC10A2) and then transported into the portal vein. Previous studies revealed that regulation of the ASBT involves BAs and cholesterol. In addition, abnormal ASBT expression and function might lead to some diseases associated with disorders in the enterohepatic circulation of BAs and cholesterol homeostasis, such as diarrhoea and gallstones. However, decreasing cholesterol or BAs by partly inhibiting ASBT-mediated transport might be used for treatments of hypercholesterolemia, cholestasis and diabetes. This review mainly discusses the regulation of the ASBT by BAs and cholesterol and its relevance to diseases and treatment.
Reply
2012, Gastroenterology
Defects in gallbladder emptying and bile acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies
2012, Gastroenterology
Citation Excerpt :
Fgf15, Shp, Ibabp, and Ostα/β all are up-regulated by BAs. The regulation of Asbt gene expression remains controversial, but there is evidence to indicate that BAs increase ileal Asbt levels.25 We infer that lower levels of BA transporters, such as ASBT and OSTα/β, in enterocytes decreased the intestinal absorption of BAs.
Patients with cystic fibrosis (CF) have poorly defined defects in biliary function. We evaluated the effects of cystic fibrosis transmembrane conductance regulator (CFTR) deficiency on the enterohepatic disposition of bile acids (BAs).
Bile secretion and BA homeostasis were investigated in Cftr^tm1Unc (Cftr^−/−) and CftrΔF508 (ΔF508) mice.
Cftr^−/− and ΔF508 mice did not grow to normal size, but did not have liver abnormalities. The gallbladders of Cftr^−/− mice were enlarged and had defects in emptying, based on ^99mtechnetium-mebrofenin scintigraphy or post-prandial variations in gallbladder volume; gallbladder contraction in response to cholecystokinin-8 was normal. Cftr^−/− mice had abnormal gallbladder bile and duodenal acidity, and overexpressed the vasoactive intestinal peptide—a myorelaxant factor for the gallbladder. The BA pool was larger in Cftr^−/− than wild-type mice, although there were no differences in fecal loss of BAs. Amounts of secondary BAs in portal blood, liver, and bile of Cftr^−/− mice were much lower than normal. Expression of genes that are induced by BAs, including fibroblast growth factor-15 and BA transporters, was lower in the ileum but higher in the gallbladders of Cftr^−/− mice, compared with wild-type mice, whereas enzymes that synthesize BA were down-regulated in livers of Cftr^−/− mice. This indicates that BAs underwent a cholecystohepatic shunt, which was confirmed using cholyl-(Ne-NBD)-lysine as a tracer. In Cftr^−/− mice, cholecystectomy reversed most changes in gene expression and partially restored circulating levels of secondary BAs. The ΔF508 mice overexpressed vasoactive intestinal peptide and had defects in gallbladder emptying and in levels of secondary BAs, but these features were less severe than in Cftr^−/− mice.
Cftr^−/− and CftrΔF508 mice have defects in gallbladder emptying that disrupt enterohepatic circulation of BAs. These defects create a shunt pathway that restricts the amount of toxic secondary BAs that enter the liver.
Bile Formation and the Enterohepatic Circulation
2012, Physiology of the Gastrointestinal Tract, Two Volume Set
Bile Formation and the Enterohepatic Circulation
2012, Physiology of the Gastrointestinal Tract

View all citing articles on Scopus

View full text